Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunome Inc.

5.93
-0.3100-4.97%
Post-market: 5.930.00000.00%19:49 EDT
Volume:1.11M
Turnover:6.58M
Market Cap:515.62M
PE:-1.04
High:6.20
Open:6.02
Low:5.75
Close:6.24
Loading ...

Company Profile

Company Name:
Immunome Inc.
Exchange:
NASDAQ
Establishment Date:
2006
Employees:
118
Office Location:
18702 N. Creek Parkway,Suite 100,Bothell,Washington,United States
Zip Code:
98011
Fax:
- -
Introduction:
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01 that targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.

Directors

Name
Position
Purnanand D. Sarma
President, Chief Executive Officer and Director
John LaMattina
Director
Michael Lefenfeld
Director
Michael Rapp
Director
Michael Widlitz
Director
Philip Wagenheim
Director
Richard Baron
Director

Shareholders

Name
Position
Purnanand D. Sarma
President, Chief Executive Officer and Director
Richard F. Fitzgerald
Chief Financial Officer
Michael J. Morin
Chief Scientific Officer